MMP-2/3 and Periapical Healing Outcomes
Association of MMP-2 and MMP-3 Polymorphisms With 12-Month Radiographic Healing After Nonsurgical Root Canal Treatment in Chronic Apical Periodontitis: A Prospective Clinical Study
1 other identifier
observational
50
0 countries
N/A
Brief Summary
This prospective randomized clinical study will investigate the association between MMP-2 and MMP-3 gene polymorphisms and radiographic healing outcomes following nonsurgical root canal treatment in patients with chronic apical periodontitis. A total of 50 patients will undergo standardized endodontic treatment and will be followed for 12 months. Genotyping will be performed using baseline DNA samples, and periapical healing will be assessed using the Periapical Index (PAI). The relationship between genetic variations and treatment outcomes will be analyzed to determine whether host-related genetic factors influence healing patterns after root canal therapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started May 2026
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 8, 2026
CompletedFirst Posted
Study publicly available on registry
April 14, 2026
CompletedStudy Start
First participant enrolled
May 15, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
May 25, 2027
Study Completion
Last participant's last visit for all outcomes
June 25, 2027
April 14, 2026
April 1, 2026
1 year
April 8, 2026
April 8, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Radiographic Periapical Healing
The primary outcome will be radiographic healing assessed using the Periapical Index (PAI) scoring system on standardized periapical radiographs.
12 months after treatment
Secondary Outcomes (1)
Association Between MMP Genotypes and Healing Outcomes
Baseline (genotyping) and 12 months after treatment
Study Arms (1)
Standardized Root Canal Treatment
Participants will undergo standardized nonsurgical root canal treatment using a uniform clinical protocol. Radiographic healing outcomes will be evaluated at 12 months, and results will be analyzed in relation to MMP-2 and MMP-3 gene polymorphisms.
Interventions
All participants will undergo standardized nonsurgical root canal treatment performed under a uniform clinical protocol. After local anesthesia and rubber dam isolation, working length will be determined electronically and radiographically. Root canal preparation will be completed with rotary instrumentation up to size 30/.06, accompanied by sodium hypochlorite irrigation, EDTA, and ultrasonic activation. Canals will then be obturated in the same visit using gutta-percha and epoxy resin-based sealer with the warm vertical condensation technique. Periapical healing outcomes at 12 months will be evaluated in relation to MMP-2 and MMP-3 genetic polymorphisms.
Eligibility Criteria
The study population will consist of adult patients aged 18-65 years diagnosed with chronic apical periodontitis in single-rooted teeth and requiring primary nonsurgical root canal treatment. All participants will be classified as ASA I or II and will be recruited from patients referred to the Department of Endodontics. Only individuals meeting the predefined inclusion and exclusion criteria will be enrolled. Participants will undergo standardized treatment and follow-up under controlled clinical conditions.
You may qualify if:
- Single-rooted teeth
- PAI score ≥ 3
- Fully developed root apices
- Periodontal probing depth less than 5 mm
- Indication for primary nonsurgical root canal treatment
You may not qualify if:
- Previous endodontic treatment in the selected tooth
- Diagnosis of symptomatic apical abscess
- Presence of root fracture or internal/external resorption
- Use of systemic antibiotics within the previous 4 weeks
- Analgesic intake within 48 hours before treatment
- Ongoing immunosuppressive therapy
- Pregnancy or breastfeeding
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer
Study Record Dates
First Submitted
April 8, 2026
First Posted
April 14, 2026
Study Start (Estimated)
May 15, 2026
Primary Completion (Estimated)
May 25, 2027
Study Completion (Estimated)
June 25, 2027
Last Updated
April 14, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share